140
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Differences in oxidative stress markers based on the aetiology of heart failure: Comparison of oxidative stress in patients with and without coronary artery disease

, , , , , , , , , , & show all
Pages 1159-1166 | Received 14 May 2009, Published online: 12 Nov 2009

References

  • Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342:1077–1084.
  • Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O'Connor CM. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997; 30:1002–1008.
  • Follath F, Cleland JG, Klein W, Murphy R. Etiology and response to drug treatment in heart failure. J Am Coll Cardiol 1998; 32:1167–1172.
  • Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358:2148–2159.
  • Nishiyama Y, Ikeda H, Haramaki N, Yoshida N, Imaizumi T. Oxidative stress is related to exercise intolerance in patients with heart failure. Am Heart J 1997; 135:115–120.
  • Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998; 31:1352–1356.
  • Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998; 97:1536–1539.
  • Hokamaki J, Kawano H, Yoshimura M, Soejima H, Miyamoto S, Kajiwara I, Kojima S, Sakamoto T, Sugiyama S, Hirai N, Shimomura H, Nagayoshi Y, Tsujita K, Shioji I, Sasaki S, Ogawa H. Urinary biopyrrins levels are elevated in relation to severity of heart failure. J Am Coll Cardiol 2004; 43:1880–1885.
  • Watanabe E, Matsuda N, Shiga T, Kajimoto K, Ajiro Y, Kawarai H, Kasanuki H, Kawana M. Significance of 8-hydroxy-2′-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy. J Card Fail 2006; 12:527–532.
  • Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984; 12:2137–2145.
  • Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004; 339:1–9.
  • Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal 2004; 6:841–849.
  • Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25:1786–1795.
  • Yamaguchi T, Shioji I, Sugimoto A, Komoda Y, Nakajima H. Chemical structure of a new family of bile pigments from human urine. J Biochem 1994; 116:298–303.
  • Shimomura H, Ogawa H, Takazoe K, Soejima H, Miyamoto S, Sakamoto T, Kawano H, Suefuji H, Nishikawa H, Arai H, Hokamaki J, Kajiwara I, Kugiyama K, Yoshimura M. Comparison of urinary biopyrrins levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events. Am J Cardiol 2002; 90:108–111.
  • Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A. CKD-JAC Study Group . Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res 2008; 3:1101–1107.
  • American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183–1197.
  • Giordano FJ. . Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115:500–508.
  • Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. . Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002; 106:927–932.
  • Botto N, Masetti S, Petrozzi L, Vassalle C, Manfredi S, Biagini A, Andreassi MG. . Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis 2002; 13:269–274.
  • Bolli R, Zughaib M, Li XY, Tang XL, Sun JZ, Triana JF, McCay PB. . Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial ‘stunning’. J Clin Invest 1995; 96:1066–1084.
  • Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, Naruke T, Ohsaka T, Nishii M, Takehana H, Izumi T. . Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 2008; 72:364–369.
  • Sakano N, Takahashi N, Wang DH, Sauriasari R, Takemoto K, Kanbara S, Sato Y, Takigawa T, Takaki J, Ogino K. . Plasma 3-nitrotyrosine, urinary 8-isoprostane and 8-OHdG among healthy Japanese people. Free Radic Res 2009; 43:183–192.
  • Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brummer J, Gutzki FM, Berger J, Frolich JC, Boger RH. . Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 2004; 109:843–848.
  • Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. . Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004; 256:308–315.
  • Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N, Takeshita A. . Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001; 88:529–535.
  • Cooke MS, Olinski R, Loft S, European Standards Committee on Urinary (DNA) Lesion Analysis. Measurement and meaning of oxidatively modified DNA lesions in urine. Cancer Epidemiol Biomarkers Prev2008; ;17:3–14.
  • Kasai H, Kawai K, Li YS. . Analysis of 8-OH-dG and 8-OH-Gua as biomarkers of oxidative stress. Genes and Environment. 2008; 30:33–40.
  • Tsutsui H, Ide T, Shiomi T, Kang D, Hayashidani S, Suematsu N, Wen J, Utsumi H, Hamasaki N, Takeshita A. . 8-Oxo-dGTPase, which prevents oxidative stress-induced DNA damage, increases in the mitochondria from failing hearts. Circulation 2001; 104:2883–2885.
  • Kono Y, Nakamura K, Kimura H, Nishii N, Watanabe A, Banba K, Miura A, Nagase S, Sakuragi S, Kusano KF, Matsubara H, Ohe T. Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. Circ J 2006; 70:1001–1005.
  • Shimoi K, Kasai H, Yokota N, Toyokuni S, Kinae N. . Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2′-deoxyguanosine in human urine. Cancer Epidemiol Biomarkers Prev 2002; 11:767–770.
  • Matsubasa T, Uchino T, Karashima S, Kondo Y, Maruyama K, Tanimura M, Endo F. Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. Free Radic Res 2002; 36:189–193.
  • Su H, Gornitsky M, Velly AM, Yu H, Benarroch M, Schipper HM. . Salivary DNA, lipid, and protein oxidation in nonsmokers with periodontal disease. Free Radic Biol Med 2009; 46:914–921.
  • Evans MD, Singh R, Mistry V, Sandhu K, Farmer PB, Cooke MS. . Analysis of urinary 8-oxo-7,8-dihydro-purine-2′-deoxyribonucleosides by LC-MS/MS and improved ELISA. Free Radic Res 2008; 42:831–840.
  • Song MF, Li YS, Ootsuyama Y, Kasai H, Kawai K, Ohta M, Eguchi Y, Yamato H, Matsumoto Y, Yoshida R, Ogawa Y. Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG. Free Radic Biol Med 2009; 47:41–46.
  • Patel PR, Bevan RJ, Mistry N, Lunec J. . Evidence of oligonucleotides containing 8-hydroxy-2′-deoxyguanosine in human urine. Free Radic Biol Med 2007; 42:552–558.
  • Cooke MS, Singh R, Hall GK, Mistry V, Duarte TL, Farmer PB, Evans MD. . Evaluation of enzyme-linked immunosorbent assay and liquid chromatography-tandem mass spectrometry methodology for the analysis of 8-oxo-7,8-dihydro-2′-deoxyguanosine in saliva and urine. Free Radic Biol Med 2006; 41:1829–1836.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.